Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus
{{output}}
Objectives: The question of whether dipeptidyl peptidase-4 inhibitors (DPP-4i) should be preferred as new glucose-lowering agents in heart failure is controversial. This studyaimed to evaluate the effects of DPP-4i treatment on a... ...
